Use of MRI and audiological tests in presymptomatic diagnosis of type 2 neurofibromatosis (NF2).
Evans
D G
DG
Newton
V
V
Neary
W
W
Baser
M E
ME
Wallace
A
A
Macleod
R
R
Jenkins
J P
JP
Gillespie
J
J
Ramsden
R T
RT
D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D001300:Audiometry, Evoked Response; D001301:Audiometry, Pure-Tone; D016543:Central Nervous System Neoplasms / Q000175:diagnosis* / Q000235:genetics; D002648:Child; D005820:Genetic Testing; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008875:Middle Aged; D016518:Neurofibromatosis 2 / Q000175:diagnosis* / Q000235:genetics; D011446:Prospective Studies; D012307:Risk Factors; D015898:Tomography Scanners, X-Ray Computed